In re: NRAD Medical Associates, P.C.

CourtUnited States Bankruptcy Court, E.D. New York
DecidedMay 29, 2026
Docket8-15-72898
StatusUnknown

This text of In re: NRAD Medical Associates, P.C. (In re: NRAD Medical Associates, P.C.) is published on Counsel Stack Legal Research, covering United States Bankruptcy Court, E.D. New York primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
In re: NRAD Medical Associates, P.C., (N.Y. 2026).

Opinion

UNITED STATES BANKRUPTCY COURT EASTERN DISTRICT OF NEW YORK ------------------------------------------------------------------x In re: Chapter 11

NRAD MEDICAL ASSOCIATES, P.C., Case No. 8-15-72898-las Debtor. ----------------------------------------------------------------------------x

MEMORANDUM DECISION AND ORDER GRANTING MOTION TO REOPEN DEBTOR’S CHAPTER 11 CASE

Before the Court is the second motion (the “Motion”) [Dkt. No. 677]1 of Alice Kim, M.D.; David Kaplan, M.D.; Corrine Tobin, M.D.; Elizabeth Lustrin, M.D.; Jay Bosworth, M.D.; Jed Pollack, M.D.; Colette Zito, as executor of the estate of Joseph Zito, M.D.; and Julian Safir, M.D. (collectively, the “Movant Former Shareholders”)2, former shareholders and creditors of the bankruptcy estate of the debtor, NRAD Medical Associates, P.C. (“NRAD” or the “Debtor”), to reopen the bankruptcy case of the Debtor pursuant to 11 U.S.C. § 350(b).3 Specifically, the Movant Former Shareholders seek to reopen the bankruptcy case so as to move the Court for derivative standing4 to bring suit on behalf of NRAD’s bankruptcy estate against NRAD’s current shareholders, Robert V. Blake, M.D.; Paul D. Cayea, M.D.; Paul S.

1 Unless otherwise stated, court filings cited herein refer to the Chapter 11 bankruptcy case, In re NRAD Medical Assocs., P.C., Case No. 8-15-72898-las, and citations to docket entries are cited as “[Dkt. No. ____]”. 2 Alice Kim, M.D. and David Kaplan, M.D., who were among the Movant Former Shareholders, are no longer being represented in this matter. On May 21, 2026, the Court entered the Order granting the application of Meyer, Suozzi, English & Klein, P.C., counsel for the Movant Former Shareholders, to withdraw as counsel of record for Alice Kim, M.D. and David Kaplan, M.D. [Dkt. No. 695]; see also Mot. to Withdraw [Dkt. No. 690]. 3 Hereinafter, title 11 of the United States Code is defined as the “Bankruptcy Code”; the Federal Rules of Bankruptcy Procedure are defined as the “Bankruptcy Rules”; and the Local Bankruptcy Rules for the United States Bankruptcy Court for the Eastern District of New York are defined as the “Local Rules.” 4 In this Memorandum Decision and Order, the Court addresses the threshold issue of whether to reopen the Debtor’s bankruptcy case and declines to rule on the proposed motion by the Movant Former Shareholders, requesting derivative standing to sue the Current Shareholders on behalf of the Debtor, or any issues related to whether the Movant Former Shareholders have waived their claims to the MLMIC Proceeds. Lang, M.D.; Robin Ehrenpreis, M.D.; Daniel Benjamin, M.D.; Gene Berkovich, M.D.; Eric Schnipper, M.D.; and Paul Schorr, M.D. (collectively, the “Current Shareholders”) for disgorgement of certain proceeds distributed to the Current Shareholders by NRAD in connection with the demutualization of the Medical Liability Mutual Insurance Company (the “MLMIC Proceeds”). In the Motion, the Movant Former Shareholders argue that, in light of the Court’s holding that the MLMIC Proceeds are property of the bankruptcy estate, “other cause” exists

pursuant to Bankruptcy Code Section 350(b) to reopen the Debtor’s case to enforce the Court’s order (the “Confirmation Order”) [Dkt. No. 564], confirming the Debtor’s Second Amended Chapter 11 Plan (the “Plan”) [Dkt. No. 496]. See Mem. of Law in Support of Mot. to Reopen at 5 [Dkt. No. 677]. In addition, the Movant Former Shareholders argue that reopening the Debtor’s case is necessary to allow them to bring certain causes of action against the Current Shareholders to return the MLMIC Proceeds to the Debtor’s estate. Id. On the other hand, the Debtor argues that its bankruptcy case should not be reopened because (1) the doctrine of equitable mootness applies; (2) the Movant Former Shareholders waived their claims to the MLMIC Proceeds because (i) they waived their claims pursuant to the NYU Transaction5, (ii) they waived their claims by failing to pursue relief after the Court’s Summary Judgment Decision (defined below), and (iii) they are not eligible to receive the MLMIC Proceeds because they ceased being shareholders of NRAD before the Debtor’s petition date and the MLMIC Proceeds are surplus proceeds; and (3) the claims of the Movant Former

5 By the end of 2017, NRAD owned Blue Dot Holdings, LLC, a holding company, which had a 52.8875% interest in Meridian Imaging Group, LLC (“Meridian”). See JSF ¶ 47. On or about July 25, 2018, NRAD transferred its ownership interest in Meridian to New York University School of Medicine (“NYU”), and NRAD received its portion of the proceeds. See id. ¶ 67. “In or about July 2018, the Former Shareholders each executed and delivered a Declaration and Release agreeing to receive payment reflecting the 13.33% discount of their Maximum Distribution, and releasing any and all claims against NYU.” Id. ¶66. Shareholders are futile because they cannot plead or establish fraud. See Debtor’s Mem. of Law in Opp. at 11-25 [Dkt. No. 680]. In reply, the Movant Former Shareholders argue, inter alia, that (1) the Debtor’s plan has not been substantially consummated because a significant sum of money now deemed by the Court to be property of the estate remains undistributed in accordance with the Plan; (2) the Movant Former Shareholders have not waived their claims; (3) the MLMIC Proceeds are not surplus proceeds but rather property of the estate, and the Movant Former Shareholders are proceeding in their capacity as creditors of the

Debtor; and (4) the claims of the Movant Former Shareholders in a potential second adversary proceeding are not futile but rather colorable. See Reply Mem. of Law in Further Support to Reopen at 2-5 [Dkt. No. 684]. The Court has carefully reviewed the parties’ submissions and heard oral argument on the Motion. For the reasons set forth below, the Court grants the Motion to reopen the Debtor’s bankruptcy case.6

JURISDICTION The Court has jurisdiction over this proceeding pursuant to 28 U.S.C. § 1334(b) and the Standing Order of Reference of the United States District Court for the Eastern District of New York, dated August 28, 1986 (Weinstein, C.J.), as amended by Order dated December 5, 2012 (Amon, C.J.) entered in accordance with 28 U.S.C. § 157(a).

BACKGROUND This section incorporates by reference the facts set forth in the Court’s prior memorandum decision and order dated January 26, 2024 (the “Summary Judgment

6 This Memorandum Decision and Order is consistent with the Court’s ruling on the Motion as set forth on the record of the hearing held on May 19, 2026. Decision”) [Adv. Dkt. No. 61]7, which was issued in the adversary proceeding Kim, et al. v. NRAD Medical Assocs. P.C. within the Debtor’s Chapter 11 case. The facts set forth in the Summary Judgement Decision were drawn from the Joint Statement of Undisputed Facts (“JSF”) [Adv. Dkt. No. 47] filed by the parties pursuant to Bankruptcy Rule 7056 and Local Rule 7056-1. In the Summary Judgment Decision, the Court granted plaintiffs’8 motion and denied defendant’s motion as to plaintiffs’ first claim for relief, holding that the MLMIC Proceeds were property of the Debtor’s bankruptcy estate. See Summ. J. Dec. at 18 [Adv. Dkt.

No. 61]. The Court also denied defendant’s motion as to plaintiffs’ second, third, fourth, and fifth claims for relief, concluding that triable issues of fact exist and that defendant had not demonstrated that no rational jury could find in favor of plaintiffs. See Summ. J. Dec. at 28 [Adv. Dkt. No. 61].

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Redmond v. Fifth Third Bank
624 F.3d 793 (Seventh Circuit, 2010)
Smith v. Silverman
645 F.3d 186 (Second Circuit, 2011)
In Re Mullendore
741 F.2d 306 (Tenth Circuit, 1984)
In Re Zinchiak
406 F.3d 214 (Third Circuit, 2005)
In Re Stein
394 B.R. 13 (E.D. New York, 2008)
In Re Smith
426 B.R. 435 (E.D. New York, 2010)
Katz v. I.A. Alliance Corp. (In Re I. Appel Corp.)
300 B.R. 564 (S.D. New York, 2003)
Texaco Inc. v. Sanders (In Re Texaco Inc.)
182 B.R. 937 (S.D. New York, 1995)
In Re Otto
311 B.R. 43 (E.D. Pennsylvania, 2004)
In Re Arana
456 B.R. 161 (E.D. New York, 2011)
Harbour Trust Co. v. Aaron (In Re Plusfunds Group, Inc.)
589 F. App'x 41 (Second Circuit, 2015)
Momentive Performance Materials Inc. v. BOKF, NA
874 F.3d 787 (Second Circuit, 2017)
Katz v. I.A. Alliance Corp.
104 F. App'x 199 (Second Circuit, 2004)
In re HBLS, L.P.
468 B.R. 634 (S.D. New York, 2012)

Cite This Page — Counsel Stack

Bluebook (online)
In re: NRAD Medical Associates, P.C., Counsel Stack Legal Research, https://law.counselstack.com/opinion/in-re-nrad-medical-associates-pc-nyeb-2026.